599
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Drospirenone plus estradiol and the risk of serious cardiovascular events in postmenopausal women

, &
Pages 349-356 | Received 15 Sep 2015, Accepted 16 Apr 2016, Published online: 13 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

M. Gambacciani, A. Cagnacci & S. Lello. (2019) Hormone replacement therapy and prevention of chronic conditions. Climacteric 22:3, pages 303-306.
Read now

Articles from other publishers (16)

E. V. Shlyakhto, G. T. Sukhikh, V. N. Serov, I. I. Dedov, G. P. Arutyunov, I. A. Suchkov, Ya. A. Orlova, E. N. Andreeva, S. V. Yureneva, I. S. Yavelov, M. I. Yarmolinskaya, S. V. Villevalde, O. R. Grigoryan, E. N. Dudinskaya, E. A. Ilyukhin, N. A. Koziolova, I. V. Sergienko, A. A. Smetnik & N. I. Tapilskaya. (2023) Russian eligibility criteria prescribing menopausal hormonal hormones therapy for patients with cardiovascular and metabolic diseases. Consensus document of the Russian Cardiological Society, Russian Society of Obstetricians and Gynecologists, Russian Association of Endocrinologists, Eurasian Association of Therapists, Association of Phlebologists of Russia. Problems of Endocrinology 69:5, pages 115-136.
Crossref
E. V. Shlyakhto, G. T. Sukhikh, V. N. Serov, I. I. Dedov, G. P. Arutyunov, I. A. Suchkov, Ya. A. Orlova, E. N. Andreeva, S. V. Yureneva, I. S. Yavelov, M. I. Yarmolinskaya, S. V. Villevalde, O. R. Grigoryan, E. N. Dudinskaya, E. A. Ilyukhin, N. A. Koziolova, I. V. Sergienko, A. A. Smetnik & N. I. Tapilskaya. (2023) Russian Eligibility Criteria for Prescribing Menopausal Hormone Therapy to Patients With Cardiovascular and Metabolic Diseases. Consensus Document of RSC, RSOG, RAE, EUAT, RAP. Kardiologiia 63:10, pages 9-28.
Crossref
S. V. Mironova & N. A. Koziolova. (2022) The use of menopausal hormone therapy in women at high cardiovascular risk. "Arterial’naya Gipertenziya" ("Arterial Hypertension") 28:4, pages 357-375.
Crossref
Yan Sun, Hui-Jie Zhang, Ran Chen, Wen-Hui Lee & Hong-Bin Zhao. (2022) 16S rDNA analysis of osteoporotic rats treated with osteoking. Journal of Medical Microbiology 71:6.
Crossref
Zhicai Peng, Ronghua Xu & Qinjian You. (2022) Role of Traditional Chinese Medicine in Bone Regeneration and Osteoporosis. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Clare Barnett, Anja Bauerfeind, Sophia von Stockum & Klaas Heinemann. (2021) Thromboembolic safety profile of low-dose estradiol (valerate) in combined hormonal preparations: Implications for the development of new hormonal endometriosis and uterine fibroid therapies. Journal of Endometriosis and Pelvic Pain Disorders 13:3, pages 195-204.
Crossref
Evgeniy V. Kryukov, Lyudmila V. Popova, Sergey V. Vasiliev, Taras S. Panevin, Anna S. Panevina, Ulyana Andreevna Stromskaya, Natalia V. Samoilova & Oleg E. Makarov. (2021) Ultra-low dose estradiol plus dydrogesterone: a role in prevention of the development and progression of atherosclerosis. Bulletin of the Russian Military Medical Academy 23:1, pages 9-14.
Crossref
Yuhao Liu, Weizai Zeng, Chao Ma, Ziyi Wang, Chao Wang, Shaobin Li, Wei He, Qingwen Zhang, Jiake Xu & Chi Zhou. (2020) Maackiain dampens osteoclastogenesis via attenuating RANKL‐stimulated NF‐κB signalling pathway and NFATc1 activity. Journal of Cellular and Molecular Medicine 24:21, pages 12308-12317.
Crossref
I. V. Kuznetsova. (2020) Endothelial dysfunction in context of women’s health disorders from menarche to menopause. Medical alphabet 4:33, pages 6-14.
Crossref
Jianbo He, Xiaojuan Li, Ziyi Wang, Samuel Bennett, Kai Chen, Zhifeng Xiao, Jiheng Zhan, Shudong Chen, Yu Hou, Junhao Chen, Shaofang Wang, Jiake Xu & Dingkun Lin. (2019) Therapeutic Anabolic and Anticatabolic Benefits of Natural Chinese Medicines for the Treatment of Osteoporosis. Frontiers in Pharmacology 10.
Crossref
О. I. Lisitsyna. (2019) Improving the quality of life in menopausal women. An overview of menopausal hormone therapy possibilities. Medical Council:13, pages 112-120.
Crossref
V. I. Podzolkov, A. E. Bragina & N. M. Podzolkovа. (2019) Menopausal hormone therapy and heart disease prevention: desired or valid?. Cardiovascular Therapy and Prevention 18:3, pages 94-106.
Crossref
O. V. Yakushevskaya. (2019) The menopause – a new chapter giving women a lust for life. Medical Council:7, pages 126-132.
Crossref
I A Ilovayskaya. (2018) Menopausal hormone treatments and risk of cardiovascular diseases: modern view. Gynecology 20:4, pages 40-43.
Crossref
Denise Rovinski, Ramon B. Ramos, Tayane M. Fighera, Gislaine K. Casanova & Poli Mara Spritzer. (2018) Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis. Thrombosis Research 168, pages 83-95.
Crossref
I S Zakharov. (2018) Opportunities for prevention and correction of genitourinary menopausal syndrome. Gynecology 20:2, pages 18-22.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.